Overview

Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice

Status:
Completed
Trial end date:
2017-04-24
Target enrollment:
Participant gender:
Summary
Defining Which Remission Criterion at Month 6 Predicts Remission at Month 12 in a Real Life Clinical Practice, in a Cohort of Rheumatoid Arthritis Patients Treated with Etanercept
Details
Lead Sponsor:
Pfizer
Treatments:
Etanercept